Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
NPJ Parkinson'S Disease|February 16, 2021
"Hot cross bun" is a potential imaging marker for the severity of cerebellar ataxia in MSA-CShuzhen Zhu, Bin Deng, Zifeng Huang, et al.NPJ Parkinson'S Disease|December 13, 2023
Mendelian randomization reveals association between retinal thickness and non-motor symptoms of Parkinson's diseaseHang Zhou, Bibiao Shen, Zifeng Huang, et al.Frontiers in Aging Neuroscience|March 27, 2020
Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson's Disease SeverityWanlin Yang, Zihan Chang, Rongfang Que, et al.Molecular Neurodegeneration|October 25, 2024
Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson's disease: association with peripheral inflammatory regulatory T-cells and SYT6Fen Xie, Bibiao Shen, Yuqi Luo, et al.Aging and Disease|August 24, 2019
Plasma Lipoprotein-associated Phospholipase A2 and Superoxide Dismutase are Independent Predicators of Cognitive Impairment in Cerebral Small Vessel Disease Patients: Diagnosis and AssessmentShuzhen Zhu, Xiaobo Wei, Xiaohua Yang, et al.Ebiomedicine|September 3, 2019
Inhibition of Nwd1 activity attenuates neuronal hyperexcitability and GluN2B phosphorylation in the hippocampusQin Yang, Zifeng Huang, Yangfu Luo, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 5, 2025
Cellular fibronectin exacerbates α-synuclein aggregation via integrin alpha4beta1 mediated PARP1 and SCD elevationZifeng Huang, Hui Zhong, Yingqiong Lu, et al.European Journal of Neurology|December 5, 2020
Cystatin C is a potential predictor of unfavorable outcomes for cerebral ischemia with intravenous tissue plasminogen activator treatment: A multicenter prospective nested case-control studyZihan Chang, Haiqiang Zou, Zhenchao Xie, et al.Aging|August 18, 2020
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitusTing Wang, Feilan Yuan, Zhenze Chen, et al.Journal of Advanced Research|May 27, 2025
Fibrinogen exacerbates α-synuclein aggregation and mitochondrial dysfunction via alpha5beta3 integrin in Parkinson's diseaseZifeng Huang, Jialing Zheng, Feilan Yuan, et al.Pageof 7